⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9619300 | 0.65 | — | — | |
| SCHEMBL3945347 | 0.58 | — | — | |
| SCHEMBL28781955 | 0.58 | — | — | |
| SCHEMBL1141552 | 0.55 | — | — | |
| SCHEMBL28785336 | 0.55 | — | — | |
| SCHEMBL3720483 | 0.51 | — | — | |
| SCHEMBL4308456 | 0.50 | — | — | |
| SCHEMBL880190 | 0.49 | — | — | |
| SCHEMBL4446045 | 0.46 | — | — | |
| Ethylene Glycol SCHEMBL2363275 | 0.43 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108690016-B | Pyrazolopyridines and uses thereof | 广东东阳光药业有限公司 | 2022-08-12 | — | — | CN | disclosed |
| EP-4004075-A1 | AQUEOUS CATIONIC POLYURETHANE DISPERSIONS | AGFA NV (BE) | 2022-06-01 | — | — | EP | disclosed |
| EP-4004077-A1 | AQUEOUS CATIONIC POLYURETHANE DISPERSIONS | AGFA NV (BE) | 2022-06-01 | — | — | EP | disclosed |
| CN-104136399-B | The pyrazolopyrimidine base inhibitor of ubiquitin activating enzyme | 米伦纽姆医药公司 | 2018-08-07 | — | — | CN | disclosed |
| CN-102666545-B | As the heterocycle Pyrazolopyrimidine analogs of JAK inhibitor | CELLZOME LTD. (GB) | 2016-04-06 | — | — | CN | disclosed |
| CN-102666545-A | Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors | CELLZOME LTD | 2012-09-12 | — | — | CN | disclosed |
| EP-1720836-A1 | 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO [D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005082859-A1 | 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPINES AS 5-HT2C RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2005-09-09 | — | — | WO | disclosed |